Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

AT&T Enters Into Agreement With Amdocs For Digital Upgrade

Published 11/13/2019, 07:27 AM
Updated 07/09/2023, 06:31 AM

AT&T Inc. (NYSE:T) has inked an agreement with Amdocs Limited (NASDAQ:DOX) to upgrade and modernize its digital business support system. The multi-year managed services agreement is part of the business transformation strategy of AT&T and is primarily aimed at bringing innovation to the market in an agile manner.

The deal has reinforced the long-standing business relationship between the two firms. Per the agreement, the companies are collaborating to augment data analytics and security programs while focusing on improved customer experience and digital enablement setup. In addition, the partnership aims to accelerate the implementation of DevOps to effectively address business priorities and evolving market conditions.

The alliance is based on the perceived demand escalation of new business and consumer applications with the wide proliferation of 5G, cloud and edge computing services. Edge computing forms a core focus area for AT&T and marks a positive stride forward in providing faster processing and potentially enhanced security for business applications. Together, the companies aim to offer a flexible tool to better analyze data and process low-latency, high-bandwidth applications. The go-to-market alliance particularly intends to enable customers to swiftly convert data into actionable intelligence, enabling unique digital experiences and smarter operations.

Notably, another leading U.S. wireless service provider – United States Cellular Corporation (NYSE:USM) – has also extended its long-term alliance with Amdocs by deploying its digital care solutions across its own network. This is likely to enable U.S. Cellular to digitize online and mobile application-based sales and ordering campaigns, thereby boosting consumer experience with greater automation. In addition, it would also facilitate better management of digital marketing efforts with more data- and analytics-driven reports. This, in turn, is expected to enable U.S. Cellular to promptly add solutions and capabilities in short iterative cycles to deliver highly agile digital-first experience to its users.

Both AT&T and Amdocs carry a Zacks Rank #3 (Hold). A better-ranked stock in the industry is Verizon Communications Inc. (NYSE:VZ) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here.

Verizon has long-term earnings growth expectation of 4.2%. It delivered an average positive earnings surprise of 2.2% in the trailing four quarters, beating estimates on each occasion.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Amdocs Limited (DOX): Free Stock Analysis Report

AT&T Inc. (T): Free Stock Analysis Report

Verizon Communications Inc. (VZ): Free Stock Analysis Report

United States Cellular Corporation (USM): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.